← Eichor
Study identifier: NCT07124949 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Chinese Migrant Population Health Cohort

Condition: Cardiovascular Diseases · Metabolic Disorders · Ageing and Geriatric Health  ·  Sponsor: Jinwei Tian

PhaseN/A
Planned participants26000
Who can joinAll sexes, 60 Years to 120 Years
Healthy volunteersYes

About this study

The Chinese Migrant Population Health Cohort is a prospective, multi-center study jointly initiated by Professor Yong Ji, President of Harbin Medical University, and Academician Guoqiang Chen, President of Hainan Medical University, in collaboration with regional partners. It targets older adults (≥60 years) who engage in seasonal migration between cold (Heilongjiang) and tropical (Hainan) regions. The primary objective is to investigate cardiovascular and metabolic disease risks, underlying biological and environmental mechanisms, and effective preventive strategies in this unique population. Participants are recruited from both origin and destination sites and undergo standardized baseline assessments, including questionnaires, physical examinations, medical imaging, biospecimen collection (blood, stool, hair, nails), and environmental exposure monitoring. Longitudinal follow-up includes periodic reassessments, remote monitoring, and data linkage with hospital information systems to capture health outcomes. The study aims to: Define migration-related health risk profiles and disease phenotypes. Elucidate biological and environmental mechanisms influencing disease onset and progression. Develop AI-driven risk prediction models and evaluate targeted interventions through nested randomized controlled trials. Translate findings into clinical guidelines and scalable cross-regional health management models. This is the first cohort in China to systematically investigate th…

This description comes directly from the study's public registry record.

Talk to the study team

Jinwei Tian, Ph.D.  ·  +86 151 1451 8233  ·  tianjinwei@hrbmu.edu.cn

Cheng Jin, Ph.D.  ·  +86 153 13298872  ·  jinch@hrbmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Harbin Medical UniversityHarbin, Heilongjiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07124949